MedMira Inc. MMIRF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score

5/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

MedMira Inc. (MMIRF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 5/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

5/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

0/100

→ Income

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — MMIRF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio130.54

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$-0.01	$2.26M	$-5.16M	-228.6%
2017	$0.00	$747.34K	$-2.66M	-356.1%
2018	$0.00	$588.87K	$-2.51M	-426.1%
2019	$0.00	$527.45K	$-2.11M	-399.4%
2020	$0.00	$919.07K	$-2.05M	-222.5%
2021	$0.00	$2.14M	$-675.8K	-31.5%
2022	$0.00	$952.13K	$-1.83M	-192.4%
2023	$0.00	$432.53K	$-2.68M	-618.6%
2024	$0.00	$412.57K	$-3.33M	-806.2%
2025	$0.00	$240.51K	$-4.52M	-1881.2%